Halaman 1 dari 32 hasil
This invention relates to novel imidazothiazole derivatives, their salts, a method for the production thereof, and anti-inflammatory compositions containing the same. More particularly, this invention relates to 2,3-di-substituted-5,6-dihydroimidazo [2,1-b] thiazole, its salts, a method for the
This invention relates to novel imidazothiazole derivatives, their salts, a method for the production thereof, and anti-inflammatory compositions containing the same. More particularly, this invention relates to 2,3-di-substituted-5,6-dihydroimidazo [2,1-b] thiazole, its salts, a method for the
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates to the use of alkylaryl polyether alcohol polymers in the treatment of chronic inflammation. More particularly, the present invention relates to the use of alkylaryl polyether alcohol polymers to reduce the
This application is a 371 of PCT/CZ98/00046 filed Oct. 2, 1998.
TECHNICAL FIELD
The invention relates to a preparation for prevention and healing of inflammation affections having a radical scavenging capacity with a large biological spectrum coverage. The preparation is applicable to the prevention
FIELD OF THE INVENTION
The invention relates to modified antibodies that specifically bind to Intercellular Adhesion Molecule-1 ("ICAM-1"), and to the use of such molecules in the treatment of inflammation. More specifically, the invention concerns modified non-human anti-ICAM-1 antibodies that, as
BACKGROUND OF THE INVENTION
1. Technical Field
This invention relates to methods for treating inflammatory conditions and to compounds and pharmaceutical compositions suitable for therein.
2. Background Information
The treatment of inflammatory conditions, such as atopic dermatitis, contact
BACKGROUND OF THE INVENTION
1. Field of the Invention
The invention generally provides compounds and compositions for use in the topical treatment of infection, inflammation or pain, a method of preparing the compounds, uses of the compounds and compositions in the preparation of medicaments for the
BACKGROUND OF THE INVENTION
1. Field of the Invention
The invention generally provides compounds and compositions for use in the topical treatment of infection, inflammation or pain, a method of preparing the compounds, uses of the compounds and compositions in the preparation of medicaments for the
FIELD OF THE INVENTION
Certain ethylene diamine compounds, pharmaceutical compositions containing them, and methods of using them for the treatment of disease states, disorders, and conditions mediated by fatty acid amide hydrolase (FAAH) activity are provided.
BACKGROUND OF THE INVENTION
Medicinal
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates to 2-(N-substituted-aminoalkyl)-5-(E)-alkylidene cyclopentanones, 2-(N-substituted-aminoalkyl)-5-(E)-arylalkylidene cyclopentanones, and derivatives thereof and their use as anti-inflammatory, analgesic and
BACKGROUND OF THE INVENTION
This invention relates to invasive medical devices for delayed/sustained release of pharmaceutical compositions from a polymer that is coated or incorporated into the devices. The purpose of the coating or delivery system on these devices is to reduce, control or even
STATEMENT REGARDING FEDERALLY SPONSORED RESEARCH & DEVELOPMENT
No Federally sponsored research and development were used in making this invention.
BACKGROUND OF THE INVENTION
Inflammatory bowel disease (IBD) encompasses a spectrum of chronic, idiopathic inflammatory disorders of the
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates to a controlled-releasing medicament-containing preparation for intra-oral use, and is more especially concerned with such a preparation (and the process of using it) in the form of a very thin extruded thermoplastic
TECHNICAL FIELD OF THE INVENTION
The present invention relates to a medical composition and use thereof for the manufacture of a topical barrier formulation, an UV-radiation absorbing formulation, or an antiviral, antifungal, or antiinflammatory formulation.
Since the first epidemiological data on
TECHNICAL FIELD
The present invention relates to a therapeutic agent for intractable leukemia.
BACKGROUND ART
Most cases of leukemia are completely cured at present; however, many cases of intractable (treatment-resistant) leukemia still exist. For example, it is known that an MLL (myeloid/lymphoid